Effect of angle correction factors of MatriXX on VMAT dose verification
Yao Lei, Tan Caiyun, Liu Hancheng, Wang Haojie, Xia Bing
Department of Raiation Oncology,First Affiliated Hospital of China Medical University,Shenyang 110001,China (Yao L,Xia B);Beijing Allcure Medical Technology Co. Ltd. All Rights Reserved,Beijing 100010,China (Tan CY,Liu HCH,Wang HJ)
Abstract：Objective To investigate the effect of the angle correction factors of ionization chamber array Matrixx on the dosimetric verification of volumetric modulated arc therapy plan. Methods The Matrixx (IBA) was put in the middle of the MultiCube Phantom. Computed tomography scan was performed and the results were sent to the Raystation treatment planning system (TPS). All data calculated from TPS and actually measured using MatriXX were gained under the following conditions:6 MV, 100 MU, 28 cm×28 cm radiation field. And the directions of beam were from 0°to 180°with an interval of 5°(except an interval of 1° from 85° to 95°). The angle correction factors (CF)(θ) cor of MatriXX were calculated by the calculated dose values from TPS and the measured values using MatriXX and then mirrored to the opposite side. CF (θ) cor values were compared with CF (θ) def values that were given by manufacturer. The comparison was made by paired t-test. Results CF (θ) cor and CF (θ) def were different, and the difference was significant between 85° and 95°, with a maximum of 7.5%(P<0.05). The CF (θ) cor correction method had a higher gamma pass rate than the CF (θ) def correction method, with a maximum of 17%(P<0.05). Conclusions The ionization chamber array MatriXX has an angular dependence and the angle correction should be performed. The angle correction factors have the individual characteristics and are different in every unit ionization chamber of the MatriXX. Therefore, it is necessary to do angle correction for every unit ionization chamber of the MatriXX and the possible errors caused by various factors should be considered in order to improve the accuracy rate and gamma pass rate of the plan verification.
Yao Lei,Tan Caiyun,Liu Hancheng et al. Effect of angle correction factors of MatriXX on VMAT dose verification[J]. Chinese Journal of Radiation Oncology, 2017, 26(12): 1434-1437.
[1] Klein EE,Hanley J,Bayouth J,et al. Task Group 142 report:quality assurance of medical accelerators[J].Med Phys,2009,36(9):4197-4212.DOI:10.1118/1.3190392. [2] Herzen J,Todorovic M,Cremers F, et al. Dosimetric evaluation of a 2D pixel ionization chamber for implementation in clinical routine[J].Phys Med Biol, 2007, 52(4):1197-1208.DOI:10.1088/0031-9155/52/4/023. [3] Bhardwaj A, Sharma SC, Patel FD, et al. U-GG-T-154:use of I’mRT MatriXX for routine dynamic MLC QA and IMRT dose verification[J].Med Phys, 2008, 35(6):2761.DOI:10.1118/1.2961905. [4] Yu M, Nelson N, Gladstone D.SU-GG-T-80:comparisons of measured doses using ion chamber and MatriXX for IMRT-QA[J].Med Phys, 2008, 35(6):2744.DOI:10.1118/1.2961832. [5] Jursinic PA, Nelms BE.A 2-D diode array and analysis software for verification of intensity modulated radiation therapy delivery[J].Med Phys, 2003, 30(5):870-879.DOI:10.1118/1.1567831. [6] 王运来, 戴相坤, 谢耩.二维电离室矩阵在调强放疗剂量验证中的应用[J].中华放射肿瘤学杂志, 2008, 17(2):150-151.DOI:10.3321/j.issn:1004-4221.2008.02.019. Wang YL, Dai XK, Xie J.The application of 2D ionization chamber away in the dose verification of IMRT[J].Chin J Radiat Onco, 2009, 17(2):150-151.DOI:10.3321/j.issn:1004-4221.2008.02.019. [7] Bedfor JL, Warrington AP.Commissioning of volumetric modulated arc therapy (VMAT)[J].Int J Radiat Oncol Biol Phys, 2009, 73(2):537-545.DOI:10.1016/j.ijrobp.2008.08.055. [8] Park JY, Lee JW, Choi KS, et al. Development of a novel quality assurance system based on rolled-up and rolled-out radiochromic films in volumetric modulated arc therapy[J].Med Phys, 2011, 38(12):6688-6696.DOI:10.1118/1.3659706. [9] Tanooka M, Doi H, Miura H, et al. Three-dimensional radiochromic film dosimetry for volumetric modulated arc therapy using a spiral water phantom[J].J Radiat Res, 2013, 54(6):1153-1159.DOI:10.1093/jrr/rrt059. [10] Fogliata A, Clivio A, Fenoglietto P, et al. Quality assurance of RapidArc in clinical practice using portal dosimetry[J].Br J Radiol, 2011, 84(1002):534-545.DOI:10.1259/bjr/72327299. [11] Mans A, Remeijer P, Olaciregui-Ruiz I, et al.3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetry[J].Radiother Oncol, 2010, 94(2):181-187.DOI:10.1016/j.radonc.2009.12.020. [12] Bucciolini M, Buonamici FB, Casati M.Verification of IMRT fields by film dosimetry[J].Med Phys, 2004, 31(1):161-168.DOI:10.1118/1.1631093. [13] Gloi AM, Buchanan RE, Zuge CL, et al. RapidArc quality assurance through MapCHECK[J].J Appl Clin Med Phys, 2011, 12(2):39-47.DOI:10.1120/jacmp.v12i2.3251. [14] Boggula R, Birkner M, Lohr F, et al. Evaluation of a 2D detector array for patient-specific VMAT QA with different setups[J].Phys Med Biol, 2011, 56(22):7163-7177.DOI:10.1088/0031-9155/56/22/011. [15] 殷蔚伯, 余子豪, 徐国镇, 等.肿瘤放疗学[M].北京:北京协和医科大学出版社, 2008:37-42. Yin WB, Yu ZH, Xu GZ, et al. Radiation oncology[M].Beijing:Beijing Union Medical University Press, 2008:37-42.
2017, Vol. 26 
